home All News open_in_new Full Article

MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet

Company to hold conference call on September 15, 2025, at 10:30 ET to review corporate highlights AUSTIN, Texas — MindWalk Holdings Corp.™ (“MindWalk™”, “Company”, “we” or “us”) (NASDAQ: HYFT), a Bio-Native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced financial results for its first fiscal quarter of 2026, ended […]


today 2 w. ago attach_file Economics



ID: 1085661721
Add Watch Country

arrow_drop_down